Dosimetric Impact and Required Clinician Time of Online Adaptive Radiotherapy Using a Newly Commercially-Available, CBCT-Based Adaptive Treatment System
Adam D. Yock(Vanderbilt University Medical Center), Michael Price(Columbia University Irving Medical Center), A.B. Chakravarthy(Vanderbilt University Medical Center), Mahmoud Ahmed(Assiut University), D.N. Ayala-Peacock(Duke Medical Center), Neil B. Newman(Vanderbilt University Medical Center)
International Journal of Radiation Oncology*Biology*Physics
October 23, 2020
Cited by 2
Related Papers
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
|International Journal of Radiation Oncology*Biology*Physics|2020|314
Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale–Associated Stroke
|JAMA Neurology|2020|205
A comparison of two prospective risk analysis methods: Traditional FMEA and a modified healthcare FMEA
|Medical Physics|2016|69
Robustness Analysis for External Beam Radiation Therapy Treatment Plans: Describing Uncertainty Scenarios and Reporting Their Dosimetric Consequences
|Practical Radiation Oncology|2018|67
Initial analysis of the dosimetric benefit and clinical resource cost of CBCT‐based online adaptive radiotherapy for patients with cancers of the cervix or rectum
|Journal of Applied Clinical Medical Physics|2021|59